{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:01:21Z","timestamp":1773658881041,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[1999,5]]},"DOI":"10.1023\/a:1007792024993","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T11:08:11Z","timestamp":1040555291000},"page":"211-216","source":"Crossref","is-referenced-by-count":11,"title":["Have We Reached the Limit with Thrombolytic Therapy?"],"prefix":"10.1007","volume":"13","author":[{"given":"Keith A.A.","family":"Fox","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"203635_CR1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","volume":"329","author":"GUSTO Investigators.","year":"1993","unstructured":"GUSTO Investigators. An international randomised trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673\u2013682.","journal-title":"N Engl J Med"},{"key":"203635_CR2","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1056\/NEJM199311253292204","volume":"329","author":"GUSTO Angiographic Investigator.","year":"1993","unstructured":"GUSTO Angiographic Investigator. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329:1615\u20131622.","journal-title":"N Engl J Med"},{"key":"203635_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9149(96)00217-2","volume":"78","author":"JL Anderson","year":"1996","unstructured":"Anderson JL, Karagounis LA, Califf RM. Metaanalysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction. Am J Cardiol 1996;78:1\u20138.","journal-title":"Am J Cardiol"},{"key":"203635_CR4","unstructured":"GUSTO Investigators. 1996"},{"key":"203635_CR5","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/0735-1097(90)90364-U","volume":"16","author":"T Yasuda","year":"1990","unstructured":"Yasuda T, Gold HK, Yaoita H, et al. Comparative effects of aspirin, a synthetic thrombin inhibitor, and a monoclonal antiplatelet glycoprotein IIb\/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparation. J Mol Cell Cardiol 1990;16:714\u2013722.","journal-title":"J Mol Cell Cardiol"},{"key":"203635_CR6","first-page":"923","volume":"6","author":"JA Leopold","year":"1995","unstructured":"Leopold JA, Loscalzo J. Platelet activation by fibrinolytic agents: A potential mechanism for resistance to thrombolysis and reocclusion after successful thrombolysis. Cor Art Dis 1995;6:923\u2013929.","journal-title":"Cor Art Dis"},{"key":"203635_CR7","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/01.CIR.94.5.891","volume":"94","author":"C Bode","year":"1996","unstructured":"Bode C, Smalling RW, Gunther B, et al. Randomised comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. Circulation 1996;94:891\u2013898.","journal-title":"Circulation"},{"key":"203635_CR8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0002-9149(90)90071-8","volume":"65","author":"AJ Six","year":"1990","unstructured":"Six AJ, Louwerenburg HW, Braams R, et al. A double-blind randomised multicenter dose ranging trial of intravenous streptokinase in acute myocardial infarction. Am J Cardiol 1990;65:119\u2013123.","journal-title":"Am J Cardiol"},{"key":"203635_CR9","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1161\/01.CIR.92.8.2050","volume":"92","author":"S Vanderschueren","year":"1995","unstructured":"Vanderschueren S, Stockx L, Wilms G, et al. Thrombolytic therapy of peripheral arterial occlusion with recombinant staphylokinase. Circulation 1995;92:2050\u20132057.","journal-title":"Circulation"},{"key":"203635_CR10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(94)91161-4","volume":"343","author":"Fibrinolytic Therapy Trialists'","year":"1994","unstructured":"Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311\u2013322.","journal-title":"Lancet"},{"key":"203635_CR11","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/01.CIR.92.5.1110","volume":"92","author":"T Lenderink","year":"1995","unstructured":"Lenderink T, Simoons ML, Van Es GA, et al. Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. Circulation 1995;92:1110\u20131116.","journal-title":"Circulation"},{"issue":"Suppl.II","key":"203635_CR12","first-page":"II291","volume":"99","author":"ISIS-2.","year":"1993","unstructured":"ISIS-2. Four-year mortality follow-up of 17,187 patients after fibrinolytic and antiplatelet therapy in suspected acute myocardial infarction (abstr). Circulation 1993;99(Suppl. II):II291.","journal-title":"Circulation"},{"key":"203635_CR13","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1161\/01.CIR.88.6.2556","volume":"88","author":"ML Simoons","year":"1993","unstructured":"Simoons ML, Arnold AER. Tailored thrombolytic therapy: A perspective. Circulation 1993;88:2556\u20132564.","journal-title":"Circulation"},{"key":"203635_CR14","first-page":"349","volume":"2","author":"ISIS Collaborative Group.","year":"1988","unstructured":"ISIS Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2 Lancet 1988;2:349\u2013360.","journal-title":"Lancet"},{"key":"203635_CR15","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0140-6736(92)91893-D","volume":"339","author":"ISIS-3.","year":"1992","unstructured":"ISIS-3. A randomised comparison of streptokinase vs. tissue plasminogen activator vs. anistreplase and of aspirin plus heparin vs. aspirin alone among 41, 299 cases of suspected acute myocardial infarction. Lancet 1992;339:753\u2013770.","journal-title":"Lancet"},{"key":"203635_CR16","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1056\/NEJM198710013171402","volume":"317","author":"HD White","year":"1987","unstructured":"White HD, Norris RM, Brown MA, et al. Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. N Engl J Med 1987;317:850\u2013855.","journal-title":"N Engl J Med"},{"key":"203635_CR17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0735-1097(92)90095-5","volume":"20","author":"W-H Leung","year":"1992","unstructured":"Leung W-H, Lau C-P. Effects of the severity of the infarct-related coronary artery on left ventricular dilatation and function after myocardial infarction. J Am Coll Cardiol 1992;20:307\u2013313.","journal-title":"J Am Coll Cardiol"},{"key":"203635_CR18","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/01.CIR.92.5.1101","volume":"92","author":"GA Lamas","year":"1995","unstructured":"Lamas GA, Flaker GC, Mitchell G, et al. Effect of infarct artery patency on prognosis after acute myocardial infarction. Circulation 1995;92:1101\u20131109.","journal-title":"Circulation"},{"key":"203635_CR19","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1161\/01.CIR.85.6.2090","volume":"85","author":"EJ Topol","year":"1992","unstructured":"Topol EJ, Califf RM, Vandormael M, et al. Thrombolysis and Angioplasty in Myocardial Infarction-6 study group. Circulation 1992;85:2090\u20132099.","journal-title":"Circulation"},{"key":"203635_CR20","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/01.CIR.90.4.2103","volume":"90","author":"WJ Rogers","year":"1994","unstructured":"Rogers WJ, Bowlby LJ, Chandra NC, et al. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation 1994;90:2103\u20132114.","journal-title":"Circulation"},{"key":"203635_CR21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/bmj.305.6851.445","volume":"305","author":"J. Birkhead","year":"1992","unstructured":"Birkhead J. Time delays in provision of thrombolytic treatment in six district hospitals. Br Med J 1992;305:445\u2013448.","journal-title":"Br Med J"},{"key":"203635_CR22","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/0735-1097(96)00053-8","volume":"27","author":"LK Newby","year":"1996","unstructured":"Newby LK, Rutsch WR, Califf RM, et al. Time from symptom onset to treatment and outcomes after thrombolytic therapy. J Am Coll Cardiol 1996;27:1646\u20131655.","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007792024993.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1007792024993\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007792024993.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T19:26:35Z","timestamp":1751052395000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1007792024993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["203635"],"URL":"https:\/\/doi.org\/10.1023\/a:1007792024993","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,5]]}}}